In this Clinical Rounds, we present a case of neuroborreliosis in a man aged 59 years who initially complained of headache, ...

Chronic pancreatitis is characterised by complex, multifactorial pain affecting 80–90% of patients. Pain arises from overlapping nociceptive and neuropathic mechanisms, often accompanied by CNS ...

The therapeutic landscape of obesity is changing rapidly, most recently with long-acting amylin agonists as a novel class of anti-obesity medications.1 Amylin is co-secreted with insulin from ...

Fibrodysplasia ossificans progressiva (FOP) is among the most devastating musculoskeletal disorders. FOP is caused by ...

Precision oncology has substantially changed the therapeutic landscape from a “one size fits all” approach to that of ...

The Lancet Oncology Commission on accelerating equitable cancer genomics and precision oncology presents a worrying picture.1 While the number of precision oncology drugs continues to increase,2,3 ...

The Lancet Oncology Commission on accelerating equitable cancer genomics and precision oncology in health care and research1 examines the gap between the promise of precision oncology and its delivery ...

The Lancet Oncology Commission on accelerating equitable access to cancer genomics and precision oncology provides an important framework defining indicators that health systems can and should measure ...

Personalised medicine has been shown to improve patient care and holds promise to further benefit treatment results. The Lancet Oncology Commission on accelerating equitable cancer genomics and ...

Blood biomarkers are transforming clinical practice for Alzheimer's disease.1 Plasma phosphorylated tau-217 (p-tau217), a highly sensitive and specific marker of Alzheimer's disease pathology,2 has ...

When American cultural anthropologist Ernest Becker was awarded the 1974 Pulitzer Prize for his book, The Denial of Death, he had died of colorectal cancer only 2 months earlier. More than half a ...

We thank Thomas Büttner and colleagues for their interest in our Article on the PrTK03 trial.1 In our trial, disease-free survival was the prospectively specified, US Food and Drug ...